Pathophysiology of propranolol in hypertension.

Abstract

Only recently approved for use in the treatment of hypertension in the US, the beta-adrenergic receptor blocking compound propranolol has been used elsewhere for this purpose since 1964. The exact mechanisms to explain why and how "beta-blocking drugs" reduce arterial pressure are not known with certainty, but possible explanations include: (1) "resetting… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.